Erdafitinib is used to treat urothelial carcinoma that’s spread in patients who have FGFR2/3 changes. It blocks FGFR signaling by functioning as a inhibitor. It’s in tablet form, and you can get it in doses of 3 mg, 4 mg, or 5 mg.
The normal dose for adults is 8 mg a day, but sometimes it might be 9 mg. Each bottle holds 56 tablets. Erdafitinib goes after the FGFR2/3 receptors that are way too active in cancer that has spread, helping to lower the cancer’s growth.
You take it once daily to keep a steady level of the drug in your system the whole time you’re treated. It’s convenient because the doses are already packed, making it easier to take the right amount every time, and helping to make sure you don’t miss any doses.
Reviews
There are no reviews yet.